Pelargonium tablets

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Pelargonium sidoides, Quantity: 30 mg (Equivalent: Pelargonium sidoides, Qty 150 mg)

Available from:

Mega Lifesciences (Australia) Pty Ltd

INN (International Name):

Pelargonium sidoides

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; crospovidone; colloidal anhydrous silica; magnesium stearate; Carnauba Wax; titanium dioxide; indigo carmine; sunset yellow FCF; purified talc; allura red AC; polyvinyl alcohol; macrogol 3350; lecithin

Administration route:

Oral

Therapeutic indications:

Treatment of acute,uncomplicated upper respiratory tract infections including common cold, acute bronchitis and acute sinusitis.

Product summary:

Visual Identification: Purple film coated round tablet; Container Type: Blister Pack; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2014-04-14